Periostin in the Pathogenesis of Skin Diseases

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2017 Sep 17

PMID 28916993

Citations 20

Authors

Hiroyuki Murota

Yang Lingli

Ichiro Katayama

Affiliations

Soon will be listed here.

Abstract

Skin is an organ that is susceptible to damage by external injury, chronic inflammation, and autoimmunity. Tissue damage causes alterations in both the configuration and type of cells in lesional skin. This phenomenon, called tissue remodeling, is a universal biological response elicited by programmed cell death, inflammation, immune disorders, and tumorigenic, tumor proliferative, and cytoreductive activity. In this process, changes in the components of the extracellular matrix are required to provide an environment that facilitates tissue remodeling. Among these extracellular matrix components, periostin, a glycoprotein that is predominantly secreted from dermal fibroblasts, has attracted attention. Periostin localizes in the papillary dermis of normal skin, and is aberrantly expressed in the dermis of lesional skin in atopic dermatitis, scar, systemic/limited scleroderma, melanoma, cutaneous T cell lymphoma, and skin damage caused by allergic/autoimmune responses. Periostin induces processes that result in the development of dermal fibrosis, and activate or protract the immune response. The aim of this review was to summarize recent knowledge of the role of periostin in the pathogenesis of dermatoses, and to explore whether periostin is a potential therapeutic target for skin diseases.

Citing Articles

Single-cell RNA sequencing analysis reveals the role of TXNDC5 in keloid formation.

Liu Z, Xian L, Li J, Zheng S, Xie H Cytojournal. 2024; 21:40.

PMID: 39563670 PMC: 11574684. DOI: 10.25259/Cytojournal_58_2024.

Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice.

Krzistetzko J, Geraud C, Dormann C, Riedel A, Leibing T FEBS Open Bio. 2024; 14(9):1455-1470.

PMID: 38946049 PMC: 11492309. DOI: 10.1002/2211-5463.13857.

Discovering and Validating Cuproptosis-Associated Marker Genes for Accurate Keloid Diagnosis Through Multiple Machine Learning Models.

Guo Z, Yu Q, Huang W, Huang F, Chen X, Wei C Clin Cosmet Investig Dermatol. 2024; 17:287-300.

PMID: 38314148 PMC: 10838519. DOI: 10.2147/CCID.S440231.

Molecular mechanisms of pruritus in prurigo nodularis.

Shao Y, Wang D, Zhu Y, Xiao Z, Jin T, Peng L Front Immunol. 2023; 14:1301817.

PMID: 38077377 PMC: 10701428. DOI: 10.3389/fimmu.2023.1301817.

What's New in Cutaneous T-Cell Lymphoma-Associated Pruritus.

Soares G, Guitart J, Yosipovitch G Am J Clin Dermatol. 2023; 25(1):67-77.

PMID: 37971624 DOI: 10.1007/s40257-023-00823-2.

References

Walker J, McLeod K, Kim S, Conway S, Hamilton D . Periostin as a multifunctional modulator of the wound healing response. Cell Tissue Res. 2016; 365(3):453-65. PMC: 5559884. DOI: 10.1007/s00441-016-2426-6. View

Bae Y, Izuhara K, Ohta S, Ono J, Hong G, Ro J . Periostin and Interleukin-13 Are Independently Related to Chronic Spontaneous Urticaria. Allergy Asthma Immunol Res. 2016; 8(5):457-60. PMC: 4921700. DOI: 10.4168/aair.2016.8.5.457. View

Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H . Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999; 14(7):1239-49. DOI: 10.1359/jbmr.1999.14.7.1239. View

Kempf W, Sander C . Classification of cutaneous lymphomas - an update. Histopathology. 2010; 56(1):57-70. DOI: 10.1111/j.1365-2559.2009.03455.x. View

Hutchenreuther J, Vincent K, Carter D, Postovit L, Leask A . CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis. J Invest Dermatol. 2015; 135(11):2805-2813. DOI: 10.1038/jid.2015.279. View

Falke L, Gholizadeh S, Goldschmeding R, Kok R, Nguyen T . Diverse origins of the myofibroblast—implications for kidney fibrosis. Nat Rev Nephrol. 2015; 11(4):233-44. DOI: 10.1038/nrneph.2014.246. View

Kotobuki Y, Yang L, Serada S, Tanemura A, Yang F, Nomura S . Periostin accelerates human malignant melanoma progression by modifying the melanoma microenvironment. Pigment Cell Melanoma Res. 2014; 27(4):630-9. DOI: 10.1111/pcmr.12245. View

Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S . Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006; 118(1):98-104. DOI: 10.1016/j.jaci.2006.02.046. View

Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A . Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer. 2007; 6:80. PMC: 2222651. DOI: 10.1186/1476-4598-6-80. View

10.

Palumbo-Zerr K, Zerr P, Distler A, Fliehr J, Mancuso R, Huang J . Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis. Nat Med. 2015; 21(2):150-8. DOI: 10.1038/nm.3777. View

11.

Furudate S, Fujimura T, Kakizaki A, Kambayashi Y, Asano M, Watabe A . The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides. Exp Dermatol. 2015; 25(2):107-12. DOI: 10.1111/exd.12873. View

12.

Murota H, Bae S, Hamasaki Y, Maruyama R, Katayama I . Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts. J Investig Allergol Clin Immunol. 2008; 18(4):245-52. View

13.

Stawski L, Han R, Bujor A, Trojanowska M . Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther. 2012; 14(4):R194. PMC: 3580592. DOI: 10.1186/ar4028. View

14.

Takeshita S, Kikuno R, Tezuka K, Amann E . Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993; 294 ( Pt 1):271-8. PMC: 1134594. DOI: 10.1042/bj2940271. View

15.

Yang L, Murota H, Serada S, Fujimoto M, Kudo A, Naka T . Histamine contributes to tissue remodeling via periostin expression. J Invest Dermatol. 2014; 134(8):2105-2113. DOI: 10.1038/jid.2014.120. View

16.

Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z . Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol. 2012; 168(4):717-25. DOI: 10.1111/bjd.12117. View

17.

Iwayama T, Olson L . Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities. Curr Rheumatol Rep. 2013; 15(2):304. PMC: 5570472. DOI: 10.1007/s11926-012-0304-0. View

18.

Fujimura T, Kakizaki A, Furudate S, Aiba S . A possible interaction between periostin and CD163 skin-resident macrophages in pemphigus vulgaris and bullous pemphigoid. Exp Dermatol. 2016; 26(12):1193-1198. DOI: 10.1111/exd.13157. View

19.

Makino K, Makino T, Stawski L, Mantero J, Lafyatis R, Simms R . Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis. J Invest Dermatol. 2017; 137(8):1671-1681. PMC: 5560111. DOI: 10.1016/j.jid.2017.03.032. View

20.

Abraham D . Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?. Rheumatology (Oxford). 2008; 47 Suppl 5:v8-9. DOI: 10.1093/rheumatology/ken278. View